Nebula Research & Development LLC Amneal Pharmaceuticals, Inc. Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 119,284 shares of AMRX stock, worth $976,935. This represents 0.12% of its overall portfolio holdings.
Number of Shares
119,284
Previous 96,783
23.25%
Holding current value
$976,935
Previous $587 Million
29.15%
% of portfolio
0.12%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$179 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$115 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$101 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$92.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$87.8 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.24B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...